Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: WhoLovesYa who wrote (60296)	5/21/1999 7:12:00 PM
From: Knighty Tin	Respond to of 132070

Greg, Incyte (INCY) is a biotech company in the gene identification field, part of the human genome project. Incyte and Human Genome Sciences (HGSI) have made huge strides in mapping the entire genetic makeup of human beings. I have owned INCY and HGSI several times, though I am currently out of HGSI on a price basis. A who's who of drug companies subscribe to Incyte's Lifeseq human gene sequence and expression database. I would wait for a down day to buy. It has been fairly strong this week. But a great co. The one negative is legal. With over 200 gene patents issued, their legitimacy has yet to be tested in court.